To Clot, Or Not
Anticoagulants in the pipeline may overcome the drawbacks of well-entrenched drugs
Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Copyright © 2024 American Chemical Society
August 16, 2010 Cover
Volume 88, Issue 33
Anticoagulants in the pipeline may overcome the drawbacks of well-entrenched drugs
Credit:
Pharmaceuticals
Recasting TSCA
Congressional hearing probes safety and other provisions of bill to reform chemical control law
Exposing The Exposome
Individuals’ records of environmental exposures may yield clues to the causes of disease
-
Safeguarding NASA's Moon Rocks
Lab at Johnson Space Center preserves 40-year-old lunar samples for study
-
Strong Demand Buoys Chemicals
Jump in earnings in the second quarter might be difficult to maintain
-
A Focus On The Cause: Rallying For Congress To Overhaul U.S. Chemical Production Law
ADVERTISEMENT
Science Concentrates
Isotopes Help Home In On Ancient Rock
Arctic region lava samples provide an unprecedented view of nascent Earth's geochemical evolution
